换一批Approval delays in multi-country COVID-19 trials: the case of COPCOV and the risk of therapeutic inertia.
第一作者：
Janelle,Winters
第一单位：
Humanitarian and Conflict Response Institute, School of Arts, Languages and Cultures, University of Manchester, Ellen Wilkinson Building, Manchester, M15 6JA, UK. janelle.winters@manchester.ac.uk.;Centre for the History of Science, Technology and Medicine, Faculty of History, University of Oxford, 45-47 Banbury Road, Oxford, OX2 0AD, UK. janelle.winters@manchester.ac.uk.
作者：
医学主题词
人类(Humans);抗病毒药(Antiviral Agents);氯喹(Chloroquine);临床试验(主题)(Clinical Trials as Topic);药物批准(Drug Approval);复方合剂(Drug Combinations);伦理学委员会, 研究(Ethics Committees, Research);羟氯喹(Hydroxychloroquine);多中心研究(主题)(Multicenter Studies as Topic);时间因素(Time Factors)
DOI
10.1186/s13063-025-09300-z
PMID
41402852
发布时间
2026-01-23
- 浏览0
Trials
58页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
